Benign prostatic hyperplasia (BPH) is a common disease associated with lower urinary tract symptoms and the most frequent benign tumor in men. To reduce BPH therapy complications, prostatic artery ...

Pune: Doctors at Manipal Hospital Kharadi successfully treated a 70-year-old gentleman who developed life-threatening urinary bleeding just three days after undergoing cardiac angioplasty.

February 11 and Cape Town has long held a significant place in South African history. From the 1990 release of Nelson Mandela from Victor Verster Prison, marking a turning point in the nation’s fight ...

Men with prostate cancer who were treated with the GnRH agonist leuprolide had significantly more coronary artery plaque progression than those receiving the GnRH antagonist relugolix.

Eighty-five original research projects from aspiring physician-scientists were on display at the 2026 Medical Student Research Forum at the Jacobs School of Medicine and Biomedical Sciences.

TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage innovator in interventional MRI (“iMRI”) procedures, is ...

Feb. 12, 2026 8:30 AM ETProfound Medical Corp. (PROF), PRN:CA “We are deeply grateful to INOVAIT for supporting a vision where AI‑enabled, image‑guided therapies like TULSA-PRO are not only developed ...

FDA clearance advances phase 2b evaluation of teverelix in advanced prostate cancer patients where ADT choice is constrained by high baseline cardiovascular risk. Trial design targets rapid, durable ...